Category: Becker’s ASC Review

'The devil is in the details' for ASC, hospital joint ventures

As the ASC industry continues to develop and evolve, so do ASCs’ relationships with health systems and hospitals.

5 states poised for ASC growth

Here are five states that could be promising locations for ASC growth based on recent development trends, and political and economic policy shifts.

The regulations making ASC development 'risky'

From Stark law to certificates of need, Shakeel Ahmed, MD, CEO of Atlas Surgical Group in St. Louis, joined Becker’s to discuss the legislation potentially stifling ASC development.

This up-and-comping ASC company sees success with a 'new generation' of physicians

New York City-based Sapient Health, a new ASC management company, has partnered with physicians to develop four new ASCs. 

American Association of Nurse Anesthesiology calls on VA secretary to grant CRNAs full practice authority

The American Association of Nurse Anesthesiology has issued a letter calling on newly confirmed Secretary of Veterans Affairs Doug Collins to grant CRNAs full practice authority. 

Regent Surgical expands C-suite

ASC development and management company Regent Surgical has added two new members to its C-Suite. Kendall Hagood will serve as chief commercial officer, while Riley Orr will serve as chief operating officer.

Sanford Health launches mail-order stool test initiative

Sioux Falls, S.D.-based Sanford Health has launched an initiative to mail stool-based screening kits for colorectal cancer directly to patient’s homes. 

How 5 GI groups are making the most of high demand

Demand for gastroenterology and endoscopy services is high as the U.S. population ages and the recently lowered clinical guidelines recommend colorectal cancer screenings at age 45. 

The fastest-growing GI procedure 

A single or multiple esophagogastroduodenoscopy biopsy is one of the fastest-growing ASC procedures, according to VMG Health’s “ASCs in 2024: A Year in Review” report.

The hidden war on ASCs

Shakeel Ahmed, MD, CEO of Atlas Surgical Group in St. Louis, joined Becker’s to discuss how hospital lobbying and other obstacles are stifling ASC development.